Canaccord Genuity Downgrades PhotoMedex (PHMD) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq touch new peaks as Treasury yields cool, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Photomedex (PHMD) Misses Q2 EPS by 8c
August 7, 2014 8:49 AM EDTPhotomedex (NASDAQ: PHMD) reported Q2 EPS of $0.01, $0.08 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $52.1 million versus the consensus estimate of $62.1 million.
For earnings history and earnings-related data on Photomedex (PHMD) click here.
... More


